Thursday, Caliper Life Sciences, Inc. (CALP), an instruments, software, and reagents company, reported a wider net loss in the fourth quarter primarily due to significant non-cash charges.
The Hopkinton, Massachusetts-based company's fourth quarter net loss widened to $46.3 million or $0.95 per share from $5.7 million or $0.12 per share in the year-ago period.
Results for the quarter include $45.3 million or $0.93 per share of non-cash goodwill impairment and other restructuring charges.
On a non-GAAP basis, the company posted a net loss of $0.02 per basic share, compared to a net loss of $0.05 per basic share a year earlier.
Quarterly revenues declined 8.8% to $36.7 million from $40.3 million in the comparable period last year. Excluding the effects of product line divestitures and unfavorable effects of foreign currency translation, revenue declined 2% from the year-ago period. Product revenue declined to $25.5 million from $28.2 million last year, service revenue declined to $8.9 million from $9.5 million, and license fees and contract revenue declined to $2.3 million from $2.6 million in the previous year.
For the full year, the company posted a net loss of $68.3 million or $1.42 per share, compared to net loss of $24.1 million or $0.51 per share in the prior year. Non-GAAP net loss was $0.27 per basic share, compared to a net loss of $0.25 per basic share in the previous year.
Revenues for the year declined to $134.0 million from $140.7 million a year ago.
Looking ahead, the company expects first-quarter revenue in the range of $25.0 to $28.0 million. For the full year 2009, Caliper anticipates organic revenue growth between 4 to 7% over 2008 pro forma revenue of $122.8 million.
CALP is currently trading at $1.03, up $0.09 or 9.57% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.